Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease Suleyman Guven, S Caner Karahan, Cagdas Bayram, Utku Ucar, Mehmet Ozeren Reproductive BioMedicine Online Volume 19, Issue 4, Pages 493-500 (October 2009) DOI: 10.1016/j.rbmo.2009.05.012 Copyright © 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK Terms and Conditions
Figure 1 Comparison of individual points for serum ischaemia-modified albumin concentrations in each group. ∗P=0.003, for polycystic ovary syndrome (PCOS) versus control group. ABSU, absorbance units. Reproductive BioMedicine Online 2009 19, 493-500DOI: (10.1016/j.rbmo.2009.05.012) Copyright © 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK Terms and Conditions
Figure 2 Scatter plots for the correlation of serum ischaemia-modified albumin concentrations and (a) Ferriman–Gallwey scores (r=0.416, P=0.007), (b) total testosterone (r=0.357, P=0.022) and (c) body mass index (r=0.3751, P=0.016) in polycystic ovary syndrome group. ABSU, absorbance units. Reproductive BioMedicine Online 2009 19, 493-500DOI: (10.1016/j.rbmo.2009.05.012) Copyright © 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK Terms and Conditions
Figure 3 Receiver operating characteristic curves for ischaemia-modified albumin. AUC, area under the curve. Reproductive BioMedicine Online 2009 19, 493-500DOI: (10.1016/j.rbmo.2009.05.012) Copyright © 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK Terms and Conditions